Choksi Laboratories Reaches 52-Week High Amid Broader Market Fluctuations

Choksi Laboratories, a microcap player in the healthcare services sector, has made headlines today as its stock price reached a new 52-week high of Rs. 223.85. This milestone was achieved on August 13, 2025, marking a significant moment for the company. However, despite this achievement, the stock underperformed its sector by 5.55% today, indicating a potential shift in momentum after a remarkable 10-day streak of gains.
Throughout the trading session, Choksi Laboratories experienced an intraday high of Rs. 223.85, reflecting a 3.32% increase, while it also saw a low of Rs. 211, down by 2.61%. Notably, the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong overall trend in its performance.

In the broader market context, the Sensex opened positively, gaining 256.58 points, and is currently trading at 80,492.35. Despite this, the Sensex has faced a slight decline of 0.32% over the past three days. Choksi Laboratories has shown impressive growth over the past year, with a remarkable 203.82% increase, significantly outpacing the Sensex's 1.95% performance during the same period.